# XPAD European Feasibility Study

> **NCT07716020** · NA · NOT_YET_RECRUITING · sponsor: **Xeltis** · enrollment: 15 (estimated)

## Conditions studied

- Peripheral Arterial Disease

## Interventions

- **DEVICE:** XPAD conduit

## Key facts

- **NCT ID:** NCT07716020
- **Lead sponsor:** Xeltis
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-12
- **Primary completion:** 2028-12
- **Final completion:** 2032-12
- **Target enrollment:** 15 (ESTIMATED)
- **Last updated:** 2026-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07716020

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07716020, "XPAD European Feasibility Study". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07716020. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*